Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
5,45 HKD | +3,81 % | -10,36 % | -57,95 % |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Li Ping Liu
CEO | Chief Executive Officer | 55 | 01.01.11 |
Koon Yin Sim
DFI | Director of Finance/CFO | 55 | 01.12.22 |
Cathryn Bennett
CTO | Chief Tech/Sci/R&D Officer | - | - |
Meng Yu
BRD | Director/Board Member | 42 | 04.05.15 |
Ru Bai
PRN | Corporate Officer/Principal | 39 | 06.02.12 |
Li Yu
SEC | Corporate Secretary | 48 | 28.02.18 |
Tian Wei Ma
PRN | Corporate Officer/Principal | 57 | 01.02.23 |
Pik Man Chu
SEC | Corporate Secretary | 27 | 11.12. |
Corporate Officer/Principal | 58 | 01.02.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Bo Tan
BRD | Director/Board Member | 51 | - |
Xun Zhu
BRD | Director/Board Member | 66 | 30.11.20 |
Jin Li
BRD | Director/Board Member | 59 | - |
Li Ping Liu
CEO | Chief Executive Officer | 55 | 01.01.11 |
Meng Yu
BRD | Director/Board Member | 42 | 04.05.15 |
Li Xiong Ma
BRD | Director/Board Member | 50 | 16.11.21 |
Feng Jiang
BRD | Director/Board Member | 45 | 16.11.22 |
Tak Wai Hung
BRD | Director/Board Member | 66 | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 514 770 668 | 61 698 382 ( 11,99 %) | 41 949 294 ( 8,149 %) | 11,99 % |
Unternehmenskontakt
Hightide Therapeutics, Inc.
18B-102, Zhonghaixin Innovation Ganli 2nd Road, Jihua Neighborhood
518112, Shenzhen
+
http://www.hightidetx.comSektor
Verlauf des Gewinns je Aktie
Jahresgewinne - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
-57,95 % | 346 Mio. | |
+9,83 % | 115 Mrd. | |
+10,80 % | 105 Mrd. | |
-10,84 % | 22,71 Mrd. | |
-1,69 % | 21,83 Mrd. | |
-10,51 % | 18,18 Mrd. | |
-41,92 % | 16,52 Mrd. | |
-15,11 % | 16,01 Mrd. | |
+6,62 % | 14,14 Mrd. | |
+17,53 % | 10,71 Mrd. |
- Börse
- Aktien
- A3EXMQ Aktie
- Unternehmen HighTide Therapeutics, Inc.